Publication | Closed Access

Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer’s Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model

Alzheimer's DiseaseCardiovascular DiseaseExperimental Whole-heart ModelMedicineCardiovascular PharmacologyExperimental PharmacologyPharmacotherapyNeurologyAging-associated DiseaseProarrhythmic EffectPharmacologyAcetylcholine-esterase Inhibitors